UC Comment Letters

This comment letter responds to the California Department of Justice’s proposed modifications to regulations governing researcher access to the Controlled Substance Utilization Review and Evaluation System (CURES). UC argues that requiring individual patient consent would effectively prevent population-level research using identified CURES data and recommends restoring provisions that permit access under existing privacy, security, and human-subject protections, including the option to restrict access to DOJ’s secure laboratory.